Tempo Scan Pacific Tbk PT operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tempo Scan Pacific Tbk PT with three other
pharmaceutical manufacturers in Asia:
Zhejiang Huahai Pharmaceutical
sales of 4.09 billion Chinese Renmimbi [US$645.15 million]
of which 48%
was Drug Sale),
Dong-A Socio Holdings Co Ltd
of South Korea
(726.17 billion Korean Won [US$680.42 million]
of which 67%
was Pharmaceutication), and
based in India
(44.61 billion Indian Rupees [US$694.64 million]
of which 100%
During the year ended December of 2016, sales at
Tempo Scan Pacific Tbk PT were 9.14 trillion Indonesian Rupiahs (US$674.40 million).
increase of 11.7%
versus 2015, when the company's sales were 8.18 trillion Indonesian Rupiahs.
This was the fifth consecutive year of sales increases at Tempo Scan Pacific Tbk PT
(and since 2011, sales have increased a total of 58%).
Sales of Consumer Products and Cosmetics saw an increase
14.3% in 2016, from
2.22 trillion Indonesian Rupiahs to 2.53 trillion Indonesian Rupiahs.